Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Coronavirus Further Delays Bard Hernia Mesh Lawsuit Trials

The first bellwether trials involving polypropylene hernia mesh products manufactured by C.R. Bard, Inc. and its Davol, Inc. subsidiary have been delayed yet again, thanks to the global coronavirus pandemic. 1st Bard Hernia Mesh Trial to Begin in September 2020 … Continue reading

Major Court Ruling Allows Johnson & Johnson Talcum Powder Lawsuits to Proceed

A federal judge in New Jersey has decided to allow plaintiffs’ experts in thousands of talcum powder lawsuits testify that the long-term use of Baby Powder and Shower-to-Shower can cause ovarian cancer. Over 16,000 Talcum Powder Ovarian Cancer Lawsuits Johnson … Continue reading

Appeals Court Hears Oral Arguments in $4.7 Billion Talcum Powder Ovarian Cancer Verdict

A three-judge panel of the Missouri Court of Appeals is considering whether or not to dismiss a $4.7 billion talcum powder ovarian cancer verdict awarded to 22 women or their surviving loved ones nearly two years ago. The verdict ranks … Continue reading

Metformin Lawsuit Seeks Compensation for Allegedly Worthless Diabetes Drugs

Bernstein Liebhard is not currently pursuing lawsuits on this drug, but if you fill out our form, we will let you know if that changes. Ascend Pharmaceutical is facing a metformin lawsuit that seeks compensation for consumers who purchased allegedly … Continue reading

Uloric Lawsuits Mount, as Tennessee Man Files New Heart Attack Claim

Uloric lawsuits continue to mount, with one of the most recent cases brought by a resident of Tennessee who suffered a heart attack several years after he began using the medication. Uloric Lawsuit Claims Failure to Warn According to a … Continue reading

Environmental Group Pushes for End to PFAS-Containing Firefighting Foams

A prominent environmental group is calling on the U.S. military and Federal Aviation Administration (FAA) to end the use of certain firefighting foams made with per- and polyfluoroalkyl substances (PFAS), a group of synthetic chemicals that have been linked to … Continue reading

Medtronic Insulin Pump Lawsuit Blames Malfunction for Diabetic Coma

A South Carolina woman who recently filed suit against Medtronic, Inc. claims a malfunctioning Model 630G MiniMed Insulin Pump left her in a diabetic coma. Medtronic Insulin Pump Malfunction Caused Overdose According to a complaint filed in the U.S. District … Continue reading

Proton Pump Inhibitor Lawsuits Near 14,000, as Federal MDL Convenes April Status Conference

Personal injury lawsuits involving Nexium, Prilosec, PrevAcid and other proton pump inhibitors continue to mount in jurisdictions around the country, with nearly 14,000 kidney injury claims now pending in the federal multidistrict litigation underway in the U.S. District Court, District … Continue reading

Women Directors May Mean Faster Drug and Medical Device Recalls

A new study suggests the presence of female board members significantly influences the speed in which medical products companies recall defective drugs and devices from the market. How Female Directors Influence Product Recalls The U.S. Food & Drug Administration (FDA) … Continue reading

Elmiron Pigmentary Maculopathy Warning on Canadian Label. Why Not United States?

The manufacturers of Elmiron (pentosan polysulfate sodium)  recently updated the drug’s Canadian label to warn of the potential for pigmentary maculopathy, a retinal disorder that can result in permanent vision loss. Yet the labeling for Elmiron sold in the United … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content